This research demonstrates the extract's antimalarial potential, inhibiting the chaperone activity of Plasmodium falciparum heat shock protein, suggesting new drug development opportunities.
The resistance of malaria parasites towards the current antimalarial therapies continues to fuel the search for new antimalarial drugs, preferably from natural sources. This study aimed to investigate the potential of the dichloromethane extract of Acanthospermum australe to inhibit Plasmodium falciparum heat shock protein 70-1 (PfHsp70-1). The plasmodium lactate dehydrogenase (pLDH) assay was used to determine the antiplasmodial activity of the crude extract against the chloroquine-sensitive P. falciparum strain 3D7. The inhibitory effect of the plant extract on the chaperone activity of P. falciparum heat shock protein 70-1 (PfHsp70-1) was determined using the ATPase, thermally induced luciferase and malate dehydrogenase (MDH) assays. The extract showed a significantly high activity against P. falciparum strain 3D7 with an IC50 value of 1.3 µg/mL. A decrease in thermally induced aggregation of MDH and luciferase was observed when each of the proteins was incubated with PfHsp70-1 only. However, an increased protein aggregation was observed when the proteins were incubated with PfHsp70-1 in the presence of the plant extract. The extract also exhibited inhibitory activity on the ATPase activity of PfHsp70-1. The results obtained from this study suggest that A. australe extract contains compounds that could target malaria parasite Hsp70 functions.
No takes yet. Share an insight, caveat, or question.
Koza et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: